Answers are grounded in this paper and cite their sources.
Combination therapy shows improved selectivity toward cancer cells in human models, suggesting enhanced anticancer effects with cyclodextrin-based nanosponges.
Combination therapy is a promising strategy in cancer treatment aiming at improving therapeutic efficacy and overcoming tumour resistance. Cyclodextrin-based nanosponges (EpCN) were developed here for the co-delivery of doxorubicin (DX),...
No takes yet. Share an insight, caveat, or question.
Thongsom et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: